BIOANCIENT: Cohort of Centenarians in Navarra (1926-1927)
Recruiting
Observational Study
Aging
Cellular Senescence
Biomarkers / Blood
Age-Related Diseases
Frailty
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 100 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 333 (estimated)
- Sponsor
- Fundacion Miguel Servet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity.
This study aims …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals aged ≥100 years
* Residents of Navarre, Spain
Exclusion Criteria:
* Clinical decompensation within the last month, including hemodynamic instability, acute illness, or hospitalization;
* End-of-life condition, defined as a clinical state of irreversible deteriora…
Contacts